Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henning Beck-Nielsen

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Ugeskrift for Laeger|October 28, 2022
Henning Beck-Nielsen
Ugeskrift for Laeger|June 8, 2012
[Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus]Henning Beck-Nielsen
Ugeskrift for Laeger|June 11, 2010
[The metabolic syndrome in the daily clinic]Henning Beck-Nielsen
Diabetes/Metabolism Research and Reviews|August 29, 2012
The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes: 'To store or not to store glucose, that's the question'Henning Beck-Nielsen
Ugeskrift for Laeger|May 7, 2002
[Insulin resistance: organ manifestations and cellular mechanisms]Henning Beck-Nielsen
Biochimica Et Biophysica Acta|September 1, 2004
The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubesMichael Gaster, Henning Beck-Nielsen
Ugeskrift for Laeger|April 18, 2002
[New actors in type 2 diabetes]Kurt Højlund, Henning Beck-Nielsen
Current Diabetes Reviews|January 29, 2008
Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?Kurt Højlund, Henning Beck-Nielsen
Biochimica Et Biophysica Acta|January 31, 2006
Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjectsMichael Gaster, Henning Beck-Nielsen
Ugeskrift for Laeger|September 14, 2012
[Type 2 diabetes in Denmark]Henning Beck-Nielsen, Jan Erik Henriksen
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Ugeskrift for Laeger|October 28, 2022
Henning Beck-Nielsen
Ugeskrift for Laeger|June 8, 2012
[Glucagon-like peptide 1 analogues in the treatment of type 2 diabetes mellitus]Henning Beck-Nielsen
Ugeskrift for Laeger|June 11, 2010
[The metabolic syndrome in the daily clinic]Henning Beck-Nielsen
Diabetes/Metabolism Research and Reviews|August 29, 2012
The role of glycogen synthase in the development of hyperglycemia in type 2 diabetes: 'To store or not to store glucose, that's the question'Henning Beck-Nielsen
Ugeskrift for Laeger|May 7, 2002
[Insulin resistance: organ manifestations and cellular mechanisms]Henning Beck-Nielsen
Biochimica Et Biophysica Acta|September 1, 2004
The reduced insulin-mediated glucose oxidation in skeletal muscle from type 2 diabetic subjects may be of genetic origin--evidence from cultured myotubesMichael Gaster, Henning Beck-Nielsen
Ugeskrift for Laeger|April 18, 2002
[New actors in type 2 diabetes]Kurt Højlund, Henning Beck-Nielsen
Current Diabetes Reviews|January 29, 2008
Impaired glycogen synthase activity and mitochondrial dysfunction in skeletal muscle: markers or mediators of insulin resistance in type 2 diabetes?Kurt Højlund, Henning Beck-Nielsen
Biochimica Et Biophysica Acta|January 31, 2006
Triacylglycerol accumulation is not primarily affected in myotubes established from type 2 diabetic subjectsMichael Gaster, Henning Beck-Nielsen
Ugeskrift for Laeger|September 14, 2012
[Type 2 diabetes in Denmark]Henning Beck-Nielsen, Jan Erik Henriksen
Pageof 22